Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

INTRODUCTION: Bronchodilators are the cornerstone of chronic obstructive pulmonary disease (COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination treatment play a pivotal role. Several LAMAs are already available on the market in different formulations, but developing...

Descripción completa

Detalles Bibliográficos
Autores principales: Ora, Josuel, Coppola, Angelo, Cazzola, Mario, Calzetta, Luigino, Rogliani, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733406/
https://www.ncbi.nlm.nih.gov/pubmed/33324119
http://dx.doi.org/10.2147/JEP.S259330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733406/
https://www.ncbi.nlm.nih.gov/pubmed/33324119
http://dx.doi.org/10.2147/JEP.S259330

Ejemplares similares